Top News

Eidogen Licenses Software to Boehringer Ingelheim




Pasadena-based Eidogen announced that Boehringer Ingelheim is pilot licensing the company's computational drug discovery platform. Eidogen's software is targeted at structural informatics, which looks to combine bioinformatics and cheminformatics. The company's platform is designed to provide target prioritization, lead discovery, and lead optimization for drug discovery companies. Eidogen is backed by Tavistock Life Sciences. More information »


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel